Variant report
Variant | nsv6185 |
---|---|
Chromosome Location | chr8:51213648-51237196 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544227943 | chr8:51213649-51213650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs562793580 | chr8:51213662-51213663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116587529 | chr8:51213666-51213667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542989419 | chr8:51213677-51213678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186573180 | chr8:51213696-51213697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374135752 | chr8:51213745-51213746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs147899158 | chr8:51213796-51213797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1584577 | chr8:51213802-51213803 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs565433218 | chr8:51213844-51213845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534907201 | chr8:51213902-51213903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551024557 | chr8:51213904-51213905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs34651805 | chr8:51213909-51213910 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs527358043 | chr8:51213914-51213915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541115338 | chr8:51213977-51213978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547746622 | chr8:51214101-51214102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564550814 | chr8:51214165-51214166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375222857 | chr8:51214174-51214175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566237003 | chr8:51214194-51214195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189838452 | chr8:51214229-51214230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146049801 | chr8:51214258-51214259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558228349 | chr8:51214268-51214269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577007669 | chr8:51214275-51214276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538031838 | chr8:51214304-51214305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553280216 | chr8:51214361-51214362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183230057 | chr8:51214374-51214375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7008382 | chr8:51214407-51214408 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs569478790 | chr8:51214423-51214424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200434587 | chr8:51214427-51214428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs368130708 | chr8:51214428-51214429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201198206 | chr8:51214429-51214430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs199848710 | chr8:51214435-51214436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs199907010 | chr8:51214436-51214437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569790182 | chr8:51214447-51214448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573378999 | chr8:51214481-51214482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540769410 | chr8:51214503-51214504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565361292 | chr8:51214554-51214555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372792021 | chr8:51214573-51214574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115190056 | chr8:51214574-51214575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs370160055 | chr8:51214619-51214620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563052371 | chr8:51214680-51214681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530375994 | chr8:51214708-51214709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs138328916 | chr8:51214723-51214724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566175678 | chr8:51214753-51214754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533536619 | chr8:51214755-51214756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs76910074 | chr8:51214756-51214757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570507611 | chr8:51214794-51214795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs149629469 | chr8:51214812-51214813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs556290203 | chr8:51214884-51214885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572197711 | chr8:51214895-51214896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568273548 | chr8:51214928-51214929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:51209400-51220600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
2 | chr8:51220600-51221000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr8:51220600-51221000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr8:51220600-51221200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr8:51221000-51223400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr8:51221000-51223600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr8:51221200-51223400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
8 | chr8:51221800-51222200 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr8:51221800-51222400 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr8:51223400-51224200 | Enhancers | Brain Germinal Matrix | brain |
11 | chr8:51223400-51224800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
12 | chr8:51223400-51225000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr8:51223600-51224400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
14 | chr8:51223800-51224600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr8:51236200-51236400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
16 | chr8:51236200-51236600 | Active TSS | Fetal Heart | heart |
17 | chr8:51236400-51237800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |